Kidney International® Managing the Symptom Burden Associated With Long-term Dialysis: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference In 2022, patients, doctors, therapists, nurses, pharmacists, and researchers came together at the KDIGO Controversies Conference, “Symptom-Based Complications in Dialysis,” to examine and agree on essential ideas about recognizing and treating symptoms in dialysis patients....
The "Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts" study, led by ISN iNET-CKD* investigators, addresses anemia's global prevalence in people living with chronic kidney disease (CKD). Read the manuscript here. Current guidelines suggest a uniform hemoglobin (Hb) range for all people with CKD, but this research examines...
Michele Provenzano summarizes the design and outcomes of the ISN-ACT Global Trials Focus’ latest “Trial of the Month” and comments on possible mechanisms of the benefit and limitations of the results. A CONVINCE-ing trial for Hemodiafiltration Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure Reviewed by Dr. Provenzano, ISN-ACT Global Trials Focus Subgroup...
Watch the webinar “Winning Steps for a Successful WCN’24 Abstract Submission and Beyond.” It’s abstract submission season! How can you write a good abstract that will get accepted to WCN’24? WCN’24 abstract reviewers Sabine Karam, Magdalena Madero, Roberto Pecoits-Filho and Rob Walker have got you covered! Follow their foolproof advice on writing a winning abstract...
The ISN-Global Kidney Health Atlas (ISN-GKHA) team has produced region-specific summary slides from the 2023 ISN-GKHA edition. Access the documents* here: Africa, Eastern and Central Europe, Latin America, Middle East, NIS and Russia, North America and the Caribbean, North and East Asia, Oceania and South East Asia, South Asia, Western Europe. Why are these slides useful? This...
Kidney International ® Editorial Selections The Power of “Negative” Experiments: Harry Goldblatt’s Pathway to Discovering How Renal Ischemia Causes Hypertension The author demonstrates that Harry Goldblatt’s willingness to conduct and publish studies with negative outcomes led to a fundamental understanding of blood pressure control within less than a decade of his initial discovery, published in...
Download This infographic was supported by an unrestricted educational grant from AstraZeneca
Download This infographic was supported by an unrestricted educational grant from Travere Therapeutics
Fergus Caskey, chair of the ISN Research Working Group, interviews ISN President Masaomi Nangaku and immediate Past President Agnes Fogo on the first guidance for the optimal conduct of translational animal studies for developing new drugs to treat kidney disease. Listen to the ISN Global Kidney Care Podcast here. Learn about: The initiative’s goal of improving translational...
The ISN-ACT Clinical Trials Toolkit, launched in 2020, is designed to guide anyone starting a clinical trial or participating as a trial site. This user-friendly online toolkit is for nephrologists and researchers in kidney care from all parts of the world – regardless of their level of clinical trial experience or local resources. The toolkit includes...
ISN i3C Network members and ISN staff at one of the recently held "Work in Progress" meetings The ISN i3C (CKDu) Network (International Consortium CKDu Collaborators) brought together more than 80 participants at two online interactive meetings held in June and July to discuss current, notable work on chronic kidney disease of unknown origin (CKDu). In...
Kidney International® has published the "International Society of Nephrology First Consensus Guidance for Pre-clinical Animal Studies in Translational Nephrology." This open-access paper was developed from the "First Consensus Meeting on Guidance for Optimal Pre-Clinical Animal Studies in Translational Nephrology" (TRANSFORM) hosted by the ISN in Brussels, Belgium, in October 2022. This is the first such guidance. The recommendations...
Watch a recording of the ISN Webinar "ISN-GKHA (Atlas): Findings and Policy Implications for Europe and for the Americas" here. Moderator Liz Lightstone joined speakers David Johnson and Ikechi Okpechi to discuss the extent of gaps in provision and access to kidney care across Europe and the Americas. The recently published 2023 ISN-Global Kidney Health Atlas...
Join Rachael Morton, principal investigator of the SWIFT trial, in conversation with ISN-ACT (clinical trials) Committee members Michael Walsh and Angela Yee Moon Wang* at 9 p.m. EDT (convert to your time zone here) on July 18. They will be joined by #NephJC representatives Swapnil Hiremath and Joel Topf to discuss the protocol for...
The ISN webinar on the first guidance on the optimal conduct of translational animal studies for developing new drugs to treat kidney disease took place on May 30, 2023. Watch the recording here. Moderators Agnes Fogo and Fergus Caskey* discussed the guidance with ISN President Masaomi Nangaku and TRANSFORM meeting Steering Committee member Richard Kitching. The guidance...
The ISN-ACT Global Trials Focus (GTF) is a monthly selection of recent interesting trials relevant to kidney care. Read the GTF for May here!
Listen to the podcast here. Michele Provenzano and Daniel O'Hara, coordinators of the ISN-ACT Global Trials Focus (GTF)*, interview international clinical trial experts and ISN-ACT (Advancing Clinical Trials) chair and deputy chair Meg Jardine and Adeera Levin. Get involved in international clinical trials in nephrology: Join the ISN-ACT Network here. Meg Jardine talks about some of...
The third edition of the ISN-Global Kidney Health Atlas (ISN-GKHA) was launched at the World Congress of Nephrology 2023. Watch the video here. Adeera Levin, ISN-GKHA founder and lead, and ISN-GKHA Co-chairs David Johnson and Aminu Bello presented features and findings from the latest edition during an interview recorded at the ISN Kidney Studio. Download the 2023...
Roberto Pecoits-Filho and Amina Rakisheva discuss the Optimization of RAASi Therapy Toolkit on the Spotlight Stage at WCN'23 Watch the WCN'23 Spotlight Sessions here. A Nephrology-Cardiology Initiative: Optimization of RAASi Therapy Toolkit* Roberto Pecoits-Filho, ISN Research Working Group member, and Amina Rakisheva, representing the Heart Failure Association of the European Society of Cardiology (HFA-ESC), discuss the...
Watch the latest ISN video abstracts from the @ISNeducation Social Media Team. Watch the videos here. The videos are based on papers from Kidney International® and Kidney International Reports®: A Novel Direct Adenosine Monophosphate Kinase Activator Ameliorates Disease Progression in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease Transitional B cell Cytokines Risk Stratify Early Borderline Rejection After Renal...
